head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2019, vol. 25, issue3
Subject Area: Dental Medicine
DOI: 10.5272/jimab.2019253.2663
Published online: 22 August 2019

Case report

J of IMAB. 2019 Jul-Sep;25(3):2663-2666;
Zornitsa MihaylovaORCID logo Corresponding Autoremail, Radomir Ugrinov, Evgeniy AleksievORCID logo, Pavel StanimirovORCID logo,
Department of Dental, Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Medical University - Sofia, Bulgaria.

Myasthenia gravis (MG) is an antibody-mediated autoimmune disorder of the neuromuscular junction. We report a case of a 34-year-old female myasthenic patient with inflammatory complications after extraction of mandibular 1st and 3rd molars. Myasthenia gravis (MG) has been diagnosed more than 10 years ago. Routine dental management in myasthenic patients is expected to be unsafe and even life-threatening. Special management considerations, as well as advice and precautions are required with which all oral health providers should be sufficiently informed. To avoid complications in patients with MG we recommend oral surgical procedures to be performed in a hospital-based maxillofacial surgery clinic.

Keywords: myasthenia gravis, tooth extraction, inflammatory complications, oral pathology, oral surgery,

pdf - Download FULL TEXT /PDF 735 KB/
Please cite this article as: Mihaylova Z, Ugrinov R, Aleksiev E, Stanimirov P. Inflammatory complications after tooth extraction in a patient with Myasthenia gravis - Case report. J of IMAB. 2019 Jul-Sep;25(3):2663-2666. DOI: 10.5272/jimab.2019253.2663

Corresponding AutorCorrespondence to: Zornitsa Mihaylova, DDS, PhD; Department of Dental, Oral and maxillofacial surgery, Faculty of Dental medicine, Medical University - Sofia; 1, G. Sofiyski str., 1431 Sofia, Bulgaria; E-mail: dr.z.mihaylova@gmail.com

1. Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016 Jul;87(4):419-25. [PubMed] [Crossref]
2. Hendricks TM, Bhatti MT, Hodge DO, Chen JJ. Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population Based Study. Am J Ophthalmol. 2019 Sept;205:99-105. [PubMed] [Crossref]
3. Berrouschot J, Baumann I, Kalischewski P, Sterker M, Schneider, D. Therapy of myasthenic crisis. Crit Care Med.1997 Jul;25(7):1228-35. [PubMed] [Crossref]
4. Patton LL, Howard Jr JF. Myasthenia gravis: dental treatment considerations. Spec Care Dentist.1997 Jan-Feb;17(1):25-32. [PubMed] [Crossref]
5. Maddison P, Sadalage G, Ambrose PA, Jacob S, Vincent A. False-positive acetylcholine receptor antibody results in patients without myasthenia gravis. J Neuroimmunol. 2019 Jul;332:69-72. [PubMed] [Crossref]
6. Statland J, Ciafaloni E. Myasthenia gravis: Five new things. Neurol Clin Pract. 2013 Apr;3(2):126-33. [PubMed] [Crossref]
7. Tamburrini A, Tacconi F, Barlattani A, Mineo TC. An update on myasthenia gravis, challenging disease for the dental profession. J Oral Sci. 2015 Sep;57(3):161-8. [PubMed] [Crossref]
8. Patil PM, Singh G, Patil SP. Dentistry and the myasthenia gravis patient: a review of the current state of the art. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2012 Feb;114(1):e1-e8. [PubMed] [Crossref]
9. Prabhu SS, Khan KA, Doudnikoff AR, Reebye UN. Anesthetic considerations for a patient with myasthenia gravis undergoing deep sedation in an outpatient oral surgery setting. J Dent Anesth Pain Med. 2019 Feb;19(1):67-72. [PubMed] [Crossref].

Received: 25 February 2019
Published online: 22 August 2019

back to Online Journal